Graves Disease Treatment Market, Global Outlook and Forecast 2022-2028
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves' disease can be wide ranging.
This report contains market size and forecasts of Graves Disease Treatment in global, including the following market information:
Global Graves Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Graves Disease Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Graves Disease Treatment companies in 2021 (%)
The global Graves Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Thyroid Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Graves Disease Treatment include Abbott, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Graves Disease Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Graves Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, by Type, 2021 (%)
Global Graves Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Global Graves Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Graves Disease Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Graves Disease Treatment revenues share in global market, 2021 (%)
Key companies Graves Disease Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Graves Disease Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Graves Disease Treatment in global, including the following market information:
Global Graves Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Graves Disease Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Graves Disease Treatment companies in 2021 (%)
The global Graves Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Thyroid Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Graves Disease Treatment include Abbott, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Graves Disease Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Graves Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, by Type, 2021 (%)
- Anti-Thyroid Medication
- Radioactive Iodine Therapy
Global Graves Disease Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospitals Pharmacies
- Retail Pharmacies
Global Graves Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Graves Disease Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Graves Disease Treatment revenues share in global market, 2021 (%)
Key companies Graves Disease Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Graves Disease Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- GlaxoSmithKline plc
- Merck & Co
- Pfizer, Inc
- RLC LABS
- AbbVie, Inc
- Mylan N.V
- Allergan, plc
- Novartis AG
- Apitope
- Amgen INC.
- Sun Pharmaceuticals Industries LTD
- Immunovant Inc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Graves Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Graves Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GRAVES DISEASE TREATMENT OVERALL MARKET SIZE
2.1 Global Graves Disease Treatment Market Size: 2021 VS 2028
2.2 Global Graves Disease Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Graves Disease Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Graves Disease Treatment Players in Global Market
3.2 Top Global Graves Disease Treatment Companies Ranked by Revenue
3.3 Global Graves Disease Treatment Revenue by Companies
3.4 Global Graves Disease Treatment Sales by Companies
3.5 Global Graves Disease Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Graves Disease Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Graves Disease Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Graves Disease Treatment Players in Global Market
3.8.1 List of Global Tier 1 Graves Disease Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Graves Disease Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Graves Disease Treatment Market Size Markets, 2021 & 2028
4.1.2 Anti-Thyroid Medication
4.1.3 Radioactive Iodine Therapy
4.2 By Type - Global Graves Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Graves Disease Treatment Revenue, 2017-2022
4.2.2 By Type - Global Graves Disease Treatment Revenue, 2023-2028
4.2.3 By Type - Global Graves Disease Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Graves Disease Treatment Sales & Forecasts
4.3.1 By Type - Global Graves Disease Treatment Sales, 2017-2022
4.3.2 By Type - Global Graves Disease Treatment Sales, 2023-2028
4.3.3 By Type - Global Graves Disease Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Graves Disease Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Graves Disease Treatment Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.2 By Application - Global Graves Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Graves Disease Treatment Revenue, 2017-2022
5.2.2 By Application - Global Graves Disease Treatment Revenue, 2023-2028
5.2.3 By Application - Global Graves Disease Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Graves Disease Treatment Sales & Forecasts
5.3.1 By Application - Global Graves Disease Treatment Sales, 2017-2022
5.3.2 By Application - Global Graves Disease Treatment Sales, 2023-2028
5.3.3 By Application - Global Graves Disease Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Graves Disease Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Graves Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Graves Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Graves Disease Treatment Revenue, 2017-2022
6.2.2 By Region - Global Graves Disease Treatment Revenue, 2023-2028
6.2.3 By Region - Global Graves Disease Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Graves Disease Treatment Sales & Forecasts
6.3.1 By Region - Global Graves Disease Treatment Sales, 2017-2022
6.3.2 By Region - Global Graves Disease Treatment Sales, 2023-2028
6.3.3 By Region - Global Graves Disease Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Graves Disease Treatment Revenue, 2017-2028
6.4.2 By Country - North America Graves Disease Treatment Sales, 2017-2028
6.4.3 US Graves Disease Treatment Market Size, 2017-2028
6.4.4 Canada Graves Disease Treatment Market Size, 2017-2028
6.4.5 Mexico Graves Disease Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Graves Disease Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Graves Disease Treatment Sales, 2017-2028
6.5.3 Germany Graves Disease Treatment Market Size, 2017-2028
6.5.4 France Graves Disease Treatment Market Size, 2017-2028
6.5.5 U.K. Graves Disease Treatment Market Size, 2017-2028
6.5.6 Italy Graves Disease Treatment Market Size, 2017-2028
6.5.7 Russia Graves Disease Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Graves Disease Treatment Market Size, 2017-2028
6.5.9 Benelux Graves Disease Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Graves Disease Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Graves Disease Treatment Sales, 2017-2028
6.6.3 China Graves Disease Treatment Market Size, 2017-2028
6.6.4 Japan Graves Disease Treatment Market Size, 2017-2028
6.6.5 South Korea Graves Disease Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Graves Disease Treatment Market Size, 2017-2028
6.6.7 India Graves Disease Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Graves Disease Treatment Revenue, 2017-2028
6.7.2 By Country - South America Graves Disease Treatment Sales, 2017-2028
6.7.3 Brazil Graves Disease Treatment Market Size, 2017-2028
6.7.4 Argentina Graves Disease Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Graves Disease Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Graves Disease Treatment Sales, 2017-2028
6.8.3 Turkey Graves Disease Treatment Market Size, 2017-2028
6.8.4 Israel Graves Disease Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Graves Disease Treatment Market Size, 2017-2028
6.8.6 UAE Graves Disease Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Graves Disease Treatment Major Product Offerings
7.1.4 Abbott Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Abbott Key News
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Corporate Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Graves Disease Treatment Major Product Offerings
7.2.4 GlaxoSmithKline plc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline plc Key News
7.3 Merck & Co
7.3.1 Merck & Co Corporate Summary
7.3.2 Merck & Co Business Overview
7.3.3 Merck & Co Graves Disease Treatment Major Product Offerings
7.3.4 Merck & Co Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Merck & Co Key News
7.4 Pfizer, Inc
7.4.1 Pfizer, Inc Corporate Summary
7.4.2 Pfizer, Inc Business Overview
7.4.3 Pfizer, Inc Graves Disease Treatment Major Product Offerings
7.4.4 Pfizer, Inc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer, Inc Key News
7.5 RLC LABS
7.5.1 RLC LABS Corporate Summary
7.5.2 RLC LABS Business Overview
7.5.3 RLC LABS Graves Disease Treatment Major Product Offerings
7.5.4 RLC LABS Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.5.5 RLC LABS Key News
7.6 AbbVie, Inc
7.6.1 AbbVie, Inc Corporate Summary
7.6.2 AbbVie, Inc Business Overview
7.6.3 AbbVie, Inc Graves Disease Treatment Major Product Offerings
7.6.4 AbbVie, Inc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.6.5 AbbVie, Inc Key News
7.7 Mylan N.V
7.7.1 Mylan N.V Corporate Summary
7.7.2 Mylan N.V Business Overview
7.7.3 Mylan N.V Graves Disease Treatment Major Product Offerings
7.7.4 Mylan N.V Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Mylan N.V Key News
7.8 Allergan, plc
7.8.1 Allergan, plc Corporate Summary
7.8.2 Allergan, plc Business Overview
7.8.3 Allergan, plc Graves Disease Treatment Major Product Offerings
7.8.4 Allergan, plc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Allergan, plc Key News
7.9 Novartis AG
7.9.1 Novartis AG Corporate Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Graves Disease Treatment Major Product Offerings
7.9.4 Novartis AG Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Novartis AG Key News
7.10 Apitope
7.10.1 Apitope Corporate Summary
7.10.2 Apitope Business Overview
7.10.3 Apitope Graves Disease Treatment Major Product Offerings
7.10.4 Apitope Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Apitope Key News
7.11 Amgen INC.
7.11.1 Amgen INC. Corporate Summary
7.11.2 Amgen INC. Graves Disease Treatment Business Overview
7.11.3 Amgen INC. Graves Disease Treatment Major Product Offerings
7.11.4 Amgen INC. Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.11.5 Amgen INC. Key News
7.12 Sun Pharmaceuticals Industries LTD
7.12.1 Sun Pharmaceuticals Industries LTD Corporate Summary
7.12.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Business Overview
7.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Major Product Offerings
7.12.4 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Sun Pharmaceuticals Industries LTD Key News
7.13 Immunovant Inc
7.13.1 Immunovant Inc Corporate Summary
7.13.2 Immunovant Inc Graves Disease Treatment Business Overview
7.13.3 Immunovant Inc Graves Disease Treatment Major Product Offerings
7.13.4 Immunovant Inc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.13.5 Immunovant Inc Key News
8 GLOBAL GRAVES DISEASE TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Graves Disease Treatment Production Capacity, 2017-2028
8.2 Graves Disease Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Graves Disease Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GRAVES DISEASE TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Graves Disease Treatment Industry Value Chain
10.2 Graves Disease Treatment Upstream Market
10.3 Graves Disease Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Graves Disease Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Graves Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Graves Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GRAVES DISEASE TREATMENT OVERALL MARKET SIZE
2.1 Global Graves Disease Treatment Market Size: 2021 VS 2028
2.2 Global Graves Disease Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Graves Disease Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Graves Disease Treatment Players in Global Market
3.2 Top Global Graves Disease Treatment Companies Ranked by Revenue
3.3 Global Graves Disease Treatment Revenue by Companies
3.4 Global Graves Disease Treatment Sales by Companies
3.5 Global Graves Disease Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Graves Disease Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Graves Disease Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Graves Disease Treatment Players in Global Market
3.8.1 List of Global Tier 1 Graves Disease Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Graves Disease Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Graves Disease Treatment Market Size Markets, 2021 & 2028
4.1.2 Anti-Thyroid Medication
4.1.3 Radioactive Iodine Therapy
4.2 By Type - Global Graves Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Graves Disease Treatment Revenue, 2017-2022
4.2.2 By Type - Global Graves Disease Treatment Revenue, 2023-2028
4.2.3 By Type - Global Graves Disease Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Graves Disease Treatment Sales & Forecasts
4.3.1 By Type - Global Graves Disease Treatment Sales, 2017-2022
4.3.2 By Type - Global Graves Disease Treatment Sales, 2023-2028
4.3.3 By Type - Global Graves Disease Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Graves Disease Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Graves Disease Treatment Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.2 By Application - Global Graves Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Graves Disease Treatment Revenue, 2017-2022
5.2.2 By Application - Global Graves Disease Treatment Revenue, 2023-2028
5.2.3 By Application - Global Graves Disease Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Graves Disease Treatment Sales & Forecasts
5.3.1 By Application - Global Graves Disease Treatment Sales, 2017-2022
5.3.2 By Application - Global Graves Disease Treatment Sales, 2023-2028
5.3.3 By Application - Global Graves Disease Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Graves Disease Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Graves Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Graves Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Graves Disease Treatment Revenue, 2017-2022
6.2.2 By Region - Global Graves Disease Treatment Revenue, 2023-2028
6.2.3 By Region - Global Graves Disease Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Graves Disease Treatment Sales & Forecasts
6.3.1 By Region - Global Graves Disease Treatment Sales, 2017-2022
6.3.2 By Region - Global Graves Disease Treatment Sales, 2023-2028
6.3.3 By Region - Global Graves Disease Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Graves Disease Treatment Revenue, 2017-2028
6.4.2 By Country - North America Graves Disease Treatment Sales, 2017-2028
6.4.3 US Graves Disease Treatment Market Size, 2017-2028
6.4.4 Canada Graves Disease Treatment Market Size, 2017-2028
6.4.5 Mexico Graves Disease Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Graves Disease Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Graves Disease Treatment Sales, 2017-2028
6.5.3 Germany Graves Disease Treatment Market Size, 2017-2028
6.5.4 France Graves Disease Treatment Market Size, 2017-2028
6.5.5 U.K. Graves Disease Treatment Market Size, 2017-2028
6.5.6 Italy Graves Disease Treatment Market Size, 2017-2028
6.5.7 Russia Graves Disease Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Graves Disease Treatment Market Size, 2017-2028
6.5.9 Benelux Graves Disease Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Graves Disease Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Graves Disease Treatment Sales, 2017-2028
6.6.3 China Graves Disease Treatment Market Size, 2017-2028
6.6.4 Japan Graves Disease Treatment Market Size, 2017-2028
6.6.5 South Korea Graves Disease Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Graves Disease Treatment Market Size, 2017-2028
6.6.7 India Graves Disease Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Graves Disease Treatment Revenue, 2017-2028
6.7.2 By Country - South America Graves Disease Treatment Sales, 2017-2028
6.7.3 Brazil Graves Disease Treatment Market Size, 2017-2028
6.7.4 Argentina Graves Disease Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Graves Disease Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Graves Disease Treatment Sales, 2017-2028
6.8.3 Turkey Graves Disease Treatment Market Size, 2017-2028
6.8.4 Israel Graves Disease Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Graves Disease Treatment Market Size, 2017-2028
6.8.6 UAE Graves Disease Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Graves Disease Treatment Major Product Offerings
7.1.4 Abbott Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Abbott Key News
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Corporate Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Graves Disease Treatment Major Product Offerings
7.2.4 GlaxoSmithKline plc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline plc Key News
7.3 Merck & Co
7.3.1 Merck & Co Corporate Summary
7.3.2 Merck & Co Business Overview
7.3.3 Merck & Co Graves Disease Treatment Major Product Offerings
7.3.4 Merck & Co Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Merck & Co Key News
7.4 Pfizer, Inc
7.4.1 Pfizer, Inc Corporate Summary
7.4.2 Pfizer, Inc Business Overview
7.4.3 Pfizer, Inc Graves Disease Treatment Major Product Offerings
7.4.4 Pfizer, Inc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer, Inc Key News
7.5 RLC LABS
7.5.1 RLC LABS Corporate Summary
7.5.2 RLC LABS Business Overview
7.5.3 RLC LABS Graves Disease Treatment Major Product Offerings
7.5.4 RLC LABS Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.5.5 RLC LABS Key News
7.6 AbbVie, Inc
7.6.1 AbbVie, Inc Corporate Summary
7.6.2 AbbVie, Inc Business Overview
7.6.3 AbbVie, Inc Graves Disease Treatment Major Product Offerings
7.6.4 AbbVie, Inc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.6.5 AbbVie, Inc Key News
7.7 Mylan N.V
7.7.1 Mylan N.V Corporate Summary
7.7.2 Mylan N.V Business Overview
7.7.3 Mylan N.V Graves Disease Treatment Major Product Offerings
7.7.4 Mylan N.V Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Mylan N.V Key News
7.8 Allergan, plc
7.8.1 Allergan, plc Corporate Summary
7.8.2 Allergan, plc Business Overview
7.8.3 Allergan, plc Graves Disease Treatment Major Product Offerings
7.8.4 Allergan, plc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Allergan, plc Key News
7.9 Novartis AG
7.9.1 Novartis AG Corporate Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Graves Disease Treatment Major Product Offerings
7.9.4 Novartis AG Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Novartis AG Key News
7.10 Apitope
7.10.1 Apitope Corporate Summary
7.10.2 Apitope Business Overview
7.10.3 Apitope Graves Disease Treatment Major Product Offerings
7.10.4 Apitope Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Apitope Key News
7.11 Amgen INC.
7.11.1 Amgen INC. Corporate Summary
7.11.2 Amgen INC. Graves Disease Treatment Business Overview
7.11.3 Amgen INC. Graves Disease Treatment Major Product Offerings
7.11.4 Amgen INC. Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.11.5 Amgen INC. Key News
7.12 Sun Pharmaceuticals Industries LTD
7.12.1 Sun Pharmaceuticals Industries LTD Corporate Summary
7.12.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Business Overview
7.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Major Product Offerings
7.12.4 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Sun Pharmaceuticals Industries LTD Key News
7.13 Immunovant Inc
7.13.1 Immunovant Inc Corporate Summary
7.13.2 Immunovant Inc Graves Disease Treatment Business Overview
7.13.3 Immunovant Inc Graves Disease Treatment Major Product Offerings
7.13.4 Immunovant Inc Graves Disease Treatment Sales and Revenue in Global (2017-2022)
7.13.5 Immunovant Inc Key News
8 GLOBAL GRAVES DISEASE TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Graves Disease Treatment Production Capacity, 2017-2028
8.2 Graves Disease Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Graves Disease Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GRAVES DISEASE TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Graves Disease Treatment Industry Value Chain
10.2 Graves Disease Treatment Upstream Market
10.3 Graves Disease Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Graves Disease Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Graves Disease Treatment in Global Market
Table 2. Top Graves Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Graves Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Graves Disease Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Graves Disease Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Graves Disease Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Graves Disease Treatment Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Graves Disease Treatment Product Type
Table 9. List of Global Tier 1 Graves Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Graves Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Graves Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Graves Disease Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Graves Disease Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Graves Disease Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Graves Disease Treatment Sales (K Units), 2023-2028
Table 16. By Application – Global Graves Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Graves Disease Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Graves Disease Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Graves Disease Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Graves Disease Treatment Sales (K Units), 2023-2028
Table 21. By Region – Global Graves Disease Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Graves Disease Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Graves Disease Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Graves Disease Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Graves Disease Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Graves Disease Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Graves Disease Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Graves Disease Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Graves Disease Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Graves Disease Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Graves Disease Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Graves Disease Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Graves Disease Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Graves Disease Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Graves Disease Treatment Sales, (K Units), 2023-2028
Table 46. Abbott Corporate Summary
Table 47. Abbott Graves Disease Treatment Product Offerings
Table 48. Abbott Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. GlaxoSmithKline plc Corporate Summary
Table 50. GlaxoSmithKline plc Graves Disease Treatment Product Offerings
Table 51. GlaxoSmithKline plc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck & Co Corporate Summary
Table 53. Merck & Co Graves Disease Treatment Product Offerings
Table 54. Merck & Co Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Pfizer, Inc Corporate Summary
Table 56. Pfizer, Inc Graves Disease Treatment Product Offerings
Table 57. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. RLC LABS Corporate Summary
Table 59. RLC LABS Graves Disease Treatment Product Offerings
Table 60. RLC LABS Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. AbbVie, Inc Corporate Summary
Table 62. AbbVie, Inc Graves Disease Treatment Product Offerings
Table 63. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Mylan N.V Corporate Summary
Table 65. Mylan N.V Graves Disease Treatment Product Offerings
Table 66. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Allergan, plc Corporate Summary
Table 68. Allergan, plc Graves Disease Treatment Product Offerings
Table 69. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Novartis AG Corporate Summary
Table 71. Novartis AG Graves Disease Treatment Product Offerings
Table 72. Novartis AG Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Apitope Corporate Summary
Table 74. Apitope Graves Disease Treatment Product Offerings
Table 75. Apitope Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Amgen INC. Corporate Summary
Table 77. Amgen INC. Graves Disease Treatment Product Offerings
Table 78. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Sun Pharmaceuticals Industries LTD Corporate Summary
Table 80. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Offerings
Table 81. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Immunovant Inc Corporate Summary
Table 83. Immunovant Inc Graves Disease Treatment Product Offerings
Table 84. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Graves Disease Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Graves Disease Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Graves Disease Treatment Production by Region, 2017-2022 (K Units)
Table 88. Global Graves Disease Treatment Production by Region, 2023-2028 (K Units)
Table 89. Graves Disease Treatment Market Opportunities & Trends in Global Market
Table 90. Graves Disease Treatment Market Drivers in Global Market
Table 91. Graves Disease Treatment Market Restraints in Global Market
Table 92. Graves Disease Treatment Raw Materials
Table 93. Graves Disease Treatment Raw Materials Suppliers in Global Market
Table 94. Typical Graves Disease Treatment Downstream
Table 95. Graves Disease Treatment Downstream Clients in Global Market
Table 96. Graves Disease Treatment Distributors and Sales Agents in Global Market
Table 1. Key Players of Graves Disease Treatment in Global Market
Table 2. Top Graves Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Graves Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Graves Disease Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Graves Disease Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Graves Disease Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Graves Disease Treatment Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Graves Disease Treatment Product Type
Table 9. List of Global Tier 1 Graves Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Graves Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Graves Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Graves Disease Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Graves Disease Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Graves Disease Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Graves Disease Treatment Sales (K Units), 2023-2028
Table 16. By Application – Global Graves Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Graves Disease Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Graves Disease Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Graves Disease Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Graves Disease Treatment Sales (K Units), 2023-2028
Table 21. By Region – Global Graves Disease Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Graves Disease Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Graves Disease Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Graves Disease Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Graves Disease Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Graves Disease Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Graves Disease Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Graves Disease Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Graves Disease Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Graves Disease Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Graves Disease Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Graves Disease Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Graves Disease Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Graves Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Graves Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Graves Disease Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Graves Disease Treatment Sales, (K Units), 2023-2028
Table 46. Abbott Corporate Summary
Table 47. Abbott Graves Disease Treatment Product Offerings
Table 48. Abbott Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. GlaxoSmithKline plc Corporate Summary
Table 50. GlaxoSmithKline plc Graves Disease Treatment Product Offerings
Table 51. GlaxoSmithKline plc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck & Co Corporate Summary
Table 53. Merck & Co Graves Disease Treatment Product Offerings
Table 54. Merck & Co Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Pfizer, Inc Corporate Summary
Table 56. Pfizer, Inc Graves Disease Treatment Product Offerings
Table 57. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. RLC LABS Corporate Summary
Table 59. RLC LABS Graves Disease Treatment Product Offerings
Table 60. RLC LABS Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. AbbVie, Inc Corporate Summary
Table 62. AbbVie, Inc Graves Disease Treatment Product Offerings
Table 63. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Mylan N.V Corporate Summary
Table 65. Mylan N.V Graves Disease Treatment Product Offerings
Table 66. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Allergan, plc Corporate Summary
Table 68. Allergan, plc Graves Disease Treatment Product Offerings
Table 69. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Novartis AG Corporate Summary
Table 71. Novartis AG Graves Disease Treatment Product Offerings
Table 72. Novartis AG Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Apitope Corporate Summary
Table 74. Apitope Graves Disease Treatment Product Offerings
Table 75. Apitope Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Amgen INC. Corporate Summary
Table 77. Amgen INC. Graves Disease Treatment Product Offerings
Table 78. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Sun Pharmaceuticals Industries LTD Corporate Summary
Table 80. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Offerings
Table 81. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Immunovant Inc Corporate Summary
Table 83. Immunovant Inc Graves Disease Treatment Product Offerings
Table 84. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Graves Disease Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Graves Disease Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Graves Disease Treatment Production by Region, 2017-2022 (K Units)
Table 88. Global Graves Disease Treatment Production by Region, 2023-2028 (K Units)
Table 89. Graves Disease Treatment Market Opportunities & Trends in Global Market
Table 90. Graves Disease Treatment Market Drivers in Global Market
Table 91. Graves Disease Treatment Market Restraints in Global Market
Table 92. Graves Disease Treatment Raw Materials
Table 93. Graves Disease Treatment Raw Materials Suppliers in Global Market
Table 94. Typical Graves Disease Treatment Downstream
Table 95. Graves Disease Treatment Downstream Clients in Global Market
Table 96. Graves Disease Treatment Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Graves Disease Treatment Segment by Type
Figure 2. Graves Disease Treatment Segment by Application
Figure 3. Global Graves Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Graves Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Graves Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Graves Disease Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Graves Disease Treatment Revenue in 2021
Figure 9. By Type - Global Graves Disease Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Graves Disease Treatment Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Graves Disease Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Graves Disease Treatment Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Graves Disease Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Graves Disease Treatment Sales Market Share, 2017-2028
Figure 19. US Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Graves Disease Treatment Sales Market Share, 2017-2028
Figure 24. Germany Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Graves Disease Treatment Sales Market Share, 2017-2028
Figure 33. China Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Graves Disease Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Graves Disease Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Graves Disease Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Graves Disease Treatment by Region, 2021 VS 2028
Figure 50. Graves Disease Treatment Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Graves Disease Treatment Segment by Type
Figure 2. Graves Disease Treatment Segment by Application
Figure 3. Global Graves Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Graves Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Graves Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Graves Disease Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Graves Disease Treatment Revenue in 2021
Figure 9. By Type - Global Graves Disease Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Graves Disease Treatment Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Graves Disease Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Graves Disease Treatment Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Graves Disease Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Graves Disease Treatment Sales Market Share, 2017-2028
Figure 19. US Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Graves Disease Treatment Sales Market Share, 2017-2028
Figure 24. Germany Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Graves Disease Treatment Sales Market Share, 2017-2028
Figure 33. China Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Graves Disease Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Graves Disease Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Graves Disease Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Graves Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Graves Disease Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Graves Disease Treatment by Region, 2021 VS 2028
Figure 50. Graves Disease Treatment Industry Value Chain
Figure 51. Marketing Channels
